Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 245

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part II, Item 1A
Chunk 245
---
 of Stockholders’ Equity and (vi) Notes to Unaudited Condensed Consolidated Financial Statements.104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

44

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 CORCEPT THERAPEUTICS INCORPORATED  Date: November 4, 2025/s/ Joseph K. Belanoff Joseph K. Belanoff, M.D.Chief Executive Officer  Date: November 4, 2025/s/Atabak Mokari Atabak Mokari Chief Financial OfficerDate:November 4, 2025/s/Joseph D. LyonJoseph D. LyonChief Accounting & Technology Officer

45